Gilead Sciences Total Liabilities 2011-2026 | GILD

Annual Total Liabilities Gilead Sciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
-	-	-	-	-	-	39 B	42.1 B	49.8 B	37.6 B	32.7 B	18.8 B	10.8 B	11.7 B	10.4 B	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
49.8 B	10.4 B	28.1 B

Total Liabilities of other stocks in the Biotechnology industry

Issuer	Total Liabilities	Price	% 24h	Market Cap	Country
FSD Pharma HUGE	6.06 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	1.98 B	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	6.56 M	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	6.99 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	707 M	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	123 M	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	6.45 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	215 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	20.4 M	-	-13.47 %	$ 169 M	France
Alpine Immune Sciences ALPN	51.9 M	-	-	$ 2.17 B	USA
ASLAN Pharmaceuticals Limited ASLN	37.9 M	-	-14.27 %	$ 1.7 M	Singapore
AstraZeneca PLC AZN	65.4 B	-	-	$ 96.9 B	Britain
CureVac N.V. CVAC	106 M	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	8.16 M	-	-1.52 %	$ 24.7 M	USA
Compugen Ltd. CGEN	18.5 M	$ 2.02	-	$ 189 M	Israel
Athira Pharma ATHA	64.4 M	-	-	$ 269 M	USA
Coherus BioSciences CHRS	197 M	$ 1.42	-	$ 166 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	71.5 M	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	330 M	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	645 K	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	6.77 M	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	104 M	-	-34.95 %	$ 21.5 M	Germany
CRISPR Therapeutics AG CRSP	343 M	$ 51.48	-	$ 4.63 B	Schweiz
Институт стволовых клеток человека ISKJ	1.1 B	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	9.38 M	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	35.1 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	84 M	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	55.8 M	$ 29.6	-	$ 1.97 B	USA
Generation Bio Co. GBIO	145 M	-	-	$ 344 M	USA
IMV IMV	38 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	75.8 M	-	-	$ 3.67 B	USA
Akouos AKUS	45.1 M	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	7.43 M	-	-	$ 7.46 M	Israel
Enlivex Therapeutics Ltd. ENLV	392 M	$ 0.69	-	$ 31.5 M	Israel
Eton Pharmaceuticals ETON	66 M	$ 30.53	1.94 %	$ 821 M	USA
Cyclacel Pharmaceuticals CYCCP	1.34 M	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	34.2 M	-	-	$ 384 M	Britain
Exelixis EXEL	683 M	$ 52.99	-	$ 14.4 B	USA
Gracell Biotechnologies GRCL	281 M	-	-	$ 3.37 B	China
Forte Biosciences FBRX	21.8 M	$ 17.0	8.49 %	$ 220 M	USA
Anika Therapeutics ANIK	42.3 M	$ 14.57	-	$ 209 M	USA
Advaxis ADXS	2.3 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	17.6 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	62.5 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	37.2 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	43.5 M	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	3.45 M	$ 2.91	-	$ 4.79 M	Israel
Aptose Biosciences APTO	37.2 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	28.4 M	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	126 M	-	-0.23 %	$ 916 M	USA